Similar skin cancer incidence seen with teledermatology

Similar skin cancer incidence seen with teledermatology
(HealthDay)—The incidence of skin cancer is similar for patients evaluated by store-and-forward (SAF) teledermatology or face-to-face (F2F) consultation, according to a study published online June 20 in the International Journal of Dermatology.

Malcolm Creighton-Smith, M.D., from the Tufts Medical Center/Tufts University School of Medicine in Boston, and colleagues conducted a retrospective study involving 434 SAF teledermatology and a subset of 587 randomly selected patients with F2F consultations.

The researchers found that a higher proportion of F2F patients had prior history of (22 versus 10 percent) and received biopsies (27.2 versus 11.5 percent; both P < 0.001). No significant differences were seen between the groups in the detection rates of any skin (9.5 for the F2F group versus 5.8 percent for the teledermatology group; P = 0.3), melanoma (0.6 versus 0 percent; P = N/A), or keratinocytic carcinoma (8.5 versus 5.5 percent; P = 0.7) after adjustment for age, immunosuppression, and personal and family history of skin cancer. In addition, the groups were similar in terms of pre-post biopsy perfect diagnostic concordance, time from initial biopsy request to biopsy (45.5 versus 47.3 days; P = 0.8), and time from biopsy to definitive treatment (67.5 versus 65.4 days; P = 0.8).

"When adjusted for presence of skin cancer risk factors, incidence of detected melanoma, keratinocytic carcinoma, and any cancer was similar between SAF teledermatology and F2F patients," the authors write.


Explore further

Few want to receive skin cancer biopsy results face-to-face

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Similar skin cancer incidence seen with teledermatology (2017, June 26) retrieved 26 June 2019 from https://medicalxpress.com/news/2017-06-similar-skin-cancer-incidence-teledermatology.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more